levallorphan has been researched along with Disease Models, Animal in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Naruse, S; Ohkubo, T; Shibata, M; Takahashi, H | 1 |
Dondio, G; Giardina, G; Hay, DW; Kotzer, CJ; Petrillo, P; Underwood, DC | 1 |
Fujiwara, N; Masaoka, T; Namba, S; Namba, Y; Nishigaki, S; Wani, T | 1 |
Bläsig, J; Herz, A | 1 |
5 other study(ies) available for levallorphan and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
[Formalin-induced minor tremor response as an indicator of pain].
Topics: Aminopyrine; Analgesics; Animals; Aspirin; Carrageenan; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Formaldehyde; Guinea Pigs; Hydrocortisone; Indomethacin; Levallorphan; Male; Morphine; Pain; Pyridinolcarbamate; Tremor | 1984 |
The antitussive activity of delta-opioid receptor stimulation in guinea pigs.
Topics: Animals; Carbazoles; Cell Line; CHO Cells; Cloning, Organism; Codeine; Cough; Cricetinae; Dextromethorphan; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Guinea Pigs; Humans; Hydrocodone; Levallorphan; Male; Naloxone; Narcotic Antagonists; Protein Binding; Pyridines; Pyrroles; Pyrrolidines; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2000 |
Opiate-antagonist reversal of neurological deficits--experimental and clinical studies.
Topics: Adult; Aged; Animals; Blood Flow Velocity; Brain Ischemia; Cats; Cerebrovascular Circulation; Chick Embryo; Disease Models, Animal; Dogs; Female; Humans; Injections, Intravenous; Levallorphan; Male; Middle Aged; Naloxone; Narcotic Antagonists; Nervous System Diseases; Tomography, X-Ray Computed | 1986 |
[Problems in quantification of provoked morphine withdrawal in rats].
Topics: Animals; Behavior, Animal; Cyclazocine; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Levallorphan; Morphine Dependence; Motor Activity; Naloxone; Rats; Substance Withdrawal Syndrome | 1974 |